Navigation Links
Marshall Edwards CEO to Present at Lazard Capital Markets Healthcare Conference
Date:11/10/2010

SAN DIEGO, Nov. 10, 2010 /PRNewswire-FirstCall/ -- Marshall Edwards, Inc.(Nasdaq: MSHL), an oncology company focused on the clinical development of novel anti-cancer therapeutics, announced today that Daniel P. Gold, Ph.D., President and Chief Executive Officer, will present an update on Marshall Edwards and its lead oncology programs at the Lazard Capital Markets Healthcare Conference on Wednesday, November 17, 2010 at 3:15 p.m. EST from the St. Regis New York. A live webcast of the presentation can be accessed at www.marshalledwardsinc.com.

About Marshall Edwards

Marshall Edwards, Inc. (Nasdaq: MSHL) is a San Diego-based oncology company focused on the clinical development of novel anti-cancer therapeutics. The Company's pipeline is derived from an investigational isoflavone technology platform that has generated a number of compounds with anti-proliferative tumor activity. These small molecules have been shown to interact with specific enzyme targets resulting in inhibition of tumor cell metabolism, a function critical for cancer cell survival. The Company's lead programs focus on two families of compounds with related but distinct mechanisms of action. The first and most advanced is a NADH oxidase inhibitor program that includes lead drug candidate NV-143. The second is a mitochondrial inhibitor program that includes NV-128 and its next-generation candidates. Both programs are expected to advance into the clinic in 2011. For more information, please visit www.marshalledwardsinc.com


'/>"/>
SOURCE Marshall Edwards, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Marshall Edwards CEO to Present at JMP Securities Healthcare Conference
2. Protege of Nobel Prize Winner Robert Edwards Carries on his IVF Legacy
3. InterMune to Present at Canaccord Adams Conference
4. Monogram Biosciences to Present at the Thomas Weisel Partners Healthcare Conference 2008
5. Verenium Corporation to Present at Canaccord Adams 28th Annual Global Growth Conference
6. SENOMYX TO WEBCAST CORPORATE PRESENTATION AT THE CANACCORD ADAMS 28TH ANNUAL GLOBAL GROWTH CONFERENCE
7. Bionovo to Present at Canaccord Adams Global Growth Conference
8. Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th
9. VIA Pharmaceuticals to Present at Fourth Annual Noble Financial Equity Conference
10. Access Pharmaceuticals to Present at the Noble Financial Equity Conference
11. Bluestar Silicones Presents Adhesive Gels for Wound Care at Medical Grade Polymers Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015 Research and Markets( http://www.researchandmarkets.com/research/3nl6s2/neuroprotection ) ... report "Neuroprotection - Drugs, Markets and Companies" ... describes the role of neuroprotection in acute disorders ... system as well as in chronic diseases such ... mechanisms of damage to neural tissues are similar ...
(Date:5/28/2015)... 2015 Natera, Inc., a leader in ... in Ultrasound in Obstetrics & Gynecology ... prenatal test (NIPT) can identify a complete molar ... A study based upon data collected in the ... about 1 in 1,000 pregnancies, although other studies ...
(Date:5/28/2015)... 28, 2015  PDS Biotechnology Corp. announces preliminary ... targeting HPV-16, has generated strong T-cell responses in ... cancer is treated by surgical removal of lesions ... non-surgical alternative. Results show that it primes and ... target, and kill precancerous and cancerous cells that ...
(Date:5/28/2015)... -- GenVec, Inc. (Nasdaq: GNVC ) today announced that ... will present a company overview at the Jefferies 2015 ... June 4, 2015. The live and ... at the following link:  http://wsw.com/webcast/jeff88/gnvc .  This link ... visit www.genvec.com , click on "Investors and Media" ...
Breaking Biology Technology:Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 2Global Neuroprotection Market Report 2015-2024 - Drugs, Markets and Companies 3First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 2First Confirmed Detection of a Complete Molar Pregnancy with Cell-Free DNA Test 3PDS Biotechnology reports positive Phase I clinical trial results in proprietary HPV-Cancer Immunotherapy 2GenVec To Present At The Jefferies Healthcare Conference 2
... , ... Adie, Molly Price-Jones, Stephen Game & Stuart Swinburne , ... Limited, Amersham Place, Little Chalfont, Buckinghamshire HP7 9NA England, ... As high throughput imaging systems, analysis algorithms and ...
... Richter-Roth, and B. Felden de Neumann , GPC Biotech AG, ... The purity of histidine-tagged proteins* purified ... the imidazole concentration in the sample and binding buffer to achieve ... We determined a concentration range of imidazole that minimized the nonspecific ...
... J. Chartier , DNA Genotek ... DNA collected with Oragene is successfully amplified using the GenomiPhi , ... quantities of DNA for downstream experiments. , ... As the genotyping of single nucleotide polymorphisms (SNPs) becomes more , ...
Cached Biology Technology:Is Z' factor the best assessment for the quality of cellular assays delivering higher content? 2Is Z' factor the best assessment for the quality of cellular assays delivering higher content? 3Is Z' factor the best assessment for the quality of cellular assays delivering higher content? 4Addition of imidazole during binding improves purity of histidine-tagged proteins 2Oragene and Whole Genome Amplification with GenomiPhi 2Oragene and Whole Genome Amplification with GenomiPhi 3Oragene and Whole Genome Amplification with GenomiPhi 4
(Date:5/14/2015)... , May 14, 2015  Verificient Technologies, ... verification and online remote proctoring, announced a ... (SaaS) company and creator of the Canvas ... the two companies will benefit from the ... As a fully integrated multifactor ...
(Date:5/8/2015)... Calif. , May 8, 2015 Synaptics Inc. ... solutions, today announced that members of the executive management team ... Morgan 43rd Annual Technology, Media and Telecom Conference Date: ... Hotel in Boston, MA ... 27, 2015 Time: 2:45pm ET Location: The New York Palace ...
(Date:4/27/2015)... 2015 NXT-ID, Inc. (NASDAQ: NXTD ) ... on the growing mobile commerce market, announces that its ... the first week of May, 2015 and will be ... Gino Pereira , Chief Executive ... company as Wocket® enters the consumer market. We would ...
Breaking Biology News(10 mins):Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Synaptics to Present at Upcoming Investor Conferences 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 2Wocket, the Smartest Wallet You Will Ever Own, Announces Shipment to Pre-order Customers 3
... open-access journal PLoS Biology, streamlines the computation required to ... influence a particular physical trait, or phenotype. Thanks to ... Akey, and Leonid Kruglyak, researchers have a more efficient ... elements that produce specific traits. , In brewer's yeast ...
... Combining partially differentiated stem cells with gene therapy can promote ... damaged spinal cords of rats, a new study shows. The ... also improves the animals' motor function and electrical conduction from ... lead to new ways of treating spinal cord injury in ...
... a study conducted at Johns Hopkins show that stem cell ... myocardial infarction, in pigs. In just two months, stem cells ... animal's damaged heart restored heart function and repaired damaged heart ... findings, first presented last fall at the 2004 Scientific Sessions ...
Cached Biology News:Improved statistical tools reveal many linked loci 2Combination therapy leads to partial recovery from spinal cord injury in rats 2Combination therapy leads to partial recovery from spinal cord injury in rats 3Stem cell therapy successfully treats heart attack in animals 2
...
... 200 series of microplate readers combines reagent ... in an affordable, easy-to-use platform for the ... unique modular design and adaptability of the ... choice of a monochromator (M200) or filter ...
... Channel Cell Lines ,High Quality, Functionally-Validated, Ion ... well known for having a critical role ... have a key function in pain, CNS ... channels have been investigated in therapeutic areas, ...
Mouse monoclonal antibody raised against a partial recombinant ARHGEF11. NCBI Entrez Gene ID = ARHGEF11...
Biology Products: